Robert T Abraham

Pfizer Worldwide Research and Development (USA)

His research interests include the regulation and functions of mTORC1 in mammalian cells, cancer therapy-induced cell and organismal stress, the biology of cellular senescence, and rewiring of metabolic pathways in cancer. A specific area of current research focuses on the impact of cyclin-dependent kinase inhibitors on nucleotide biosynthesis, stress-response pathways, cellular senescence, and therapeutic resistance mechanisms.